title: Response to Hex et al. Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs.
authors.forename: R
authors.initials: R
authors.lastname: Waldeyer
authors.forename: R
authors.initials: R
authors.lastname: Brinks
authors.forename: G
authors.initials: G
authors.lastname: Giani
mesh_terms: D017281:Cost of Illness; D003922:Diabetes Mellitus, Type 1 / Q000191:economics*; D003924:Diabetes Mellitus, Type 2 / Q000191:economics*; D004526:Efficiency; D005260:Female; D005102:Health Expenditures / Q000706:statistics & numerical data*; D006295:Health Resources / Q000191:economics*; D006801:Humans; D008297:Male; D009313:National Health Programs / Q000191:economics*; D011322:Primary Prevention / Q000191:economics*